Table 2 Patients’ characteristics and results of LAG3 expression
|  | mRNA (N = 86) | IHC (N = 37) |
|---|---|---|
Characteristics | Values | Values |
Age, Mean | 63.1 | 66.3 |
Sex | ||
 Male | 70 (81.6%) | 32 (86.5%) |
 Female | 16 (18.4%) | 5 (13.5%) |
Stage | ||
 I | 10 (11.5%) | 11 (29.7%) |
 II | 16 (18.4%) | 8 (21.6%) |
 III | 44 (51.7%) | 11 (29.7%) |
 IV | 16 (18.4%) | 7 (18.9%) |
Histology | ||
 Epithelioid | 57 (65.5%) | 26 (70.3%) |
 Biphasic | 23 (31.0%) | 5 (13.5%) |
 Sarcomatoid | 1 (2.3%) | 5 (13.5%) |
 Unknown | 5 (5.7%) | 1 (2.7%) |
LAG3 | ||
 High (mRNA), Positive (IHC) | 34 (39.5%) | 10 (27.0%) |
 Low (mRNA), Negative (IHC) | 52 (60.5%) | 27 (73.0%) |
Smoking history | ||
 Never |  | 9 (24.3%) |
 Ex + Current |  | 28 (75.7%) |
Respiratory function test | ||
 %VC ≥ 80 |  | 12 (32.4%) |
 %VC < 80 |  | 19 (51.4%) |
 Unknown |  | 6 (16.2%) |